54Gene went through Y Combinator in the Winter 2019 batch, describing itself as Precision medicine for Africans and the global population. Y Combinator's company directory lists it as Inactive. The directory does not say why a company stopped, and this page does not guess.
- Batch
- Winter 2019
- What they did
- Precision medicine for Africans and the global population
- Industry
- Healthcare
- Team size
- 47
- Based
- Lagos, LA, Nigeria; LA, Nigeria
- Status
- Inactive, as listed by Y Combinator
Its batch
Winter 2019 had 194 companies in YC's listing: 118 Active, 33 Acquired, 0 Public and 43 Inactive, so 54Gene is one of 43 companies from that batch listed as Inactive (22%). Across YC batches at least two years old, 23% of companies are listed Inactive.
Statuses are Y Combinator's own listing in its public company directory, read on the date shown. YC's directory can drop companies altogether, so the Inactive counts here are a floor, not a full count of companies that stopped. Acquired and Public are as YC lists them; neither says anything about the price or the outcome for founders.
The record: 54Gene in the Y Combinator directory. Measured 2026-09-26 from Y Combinator's company directory.
YC Winter 2019All shut-down YC companiesYC outcomes
Tools for this story
Each opens in a new tab, filled in for 54Gene. With no account yet, you sign up free and land on the result.